TipRanks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Faces EU Setback on Aumolertinib but Vows Rapid Reapplication
Company AnnouncementsHansoh Faces EU Setback on Aumolertinib but Vows Rapid Reapplication
3m ago
3692
Hansoh Pharma’s Osteosarcoma Biologic HS-20093 Accepted for Review by China’s NMPA
PremiumCompany Announcements
Hansoh Pharma’s Osteosarcoma Biologic HS-20093 Accepted for Review by China’s NMPA
3d ago
3692
Hansoh’s Osteosarcoma Drug HS-20093 Wins NMPA Priority Review in China
PremiumCompany Announcements
Hansoh’s Osteosarcoma Drug HS-20093 Wins NMPA Priority Review in China
5d ago
3692
Hansoh Pharma’s TYK2 Psoriasis Drug Clears Key Phase III Trial Milestone
PremiumCompany Announcements
Hansoh Pharma’s TYK2 Psoriasis Drug Clears Key Phase III Trial Milestone
6d ago
3692
Hansoh Pharma Wins NMPA Nod for Clinical Trials of Innovative Cancer Drug HS-20197
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod for Clinical Trials of Innovative Cancer Drug HS-20197
11d ago
3692
Hansoh’s Lung Cancer Drug HS-20093 Wins NMPA Priority Review
PremiumCompany AnnouncementsHansoh’s Lung Cancer Drug HS-20093 Wins NMPA Priority Review
16d ago
3692
Hansoh Pharma’s HS-20093 ADC for Small Cell Lung Cancer Accepted by China’s NMPA
Premium
Company Announcements
Hansoh Pharma’s HS-20093 ADC for Small Cell Lung Cancer Accepted by China’s NMPA
25d ago
3692
Hansoh boosts profit on innovative drugs as lung cancer portfolio wins EU and China approvals
Premium
Company Announcements
Hansoh boosts profit on innovative drugs as lung cancer portfolio wins EU and China approvals
1M ago
3692
Hansoh Pharmaceutical Declares Interim Dividend for First Half of 2026
PremiumCompany Announcements
Hansoh Pharmaceutical Declares Interim Dividend for First Half of 2026
1M ago
3692
Analyst Reiterates Buy on Hansoh, Raising Target Price on Robust Innovative Drug Growth and Expanding Late-Stage Pipeline
PremiumRatings
Analyst Reiterates Buy on Hansoh, Raising Target Price on Robust Innovative Drug Growth and Expanding Late-Stage Pipeline
1M ago
Hansoh Pharma Wins NMPA Nod for Clinical Trials of New Cholesterol Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod for Clinical Trials of New Cholesterol Drug
2M ago
3692
Hansoh Pharmaceutical Schedules Board Meeting to Approve Interim Results and Dividend
PremiumCompany Announcements
Hansoh Pharmaceutical Schedules Board Meeting to Approve Interim Results and Dividend
2M ago
3692
Hansoh’s Osteosarcoma Drug HS-20093 Hits Phase III Target, China Filing Planned
PremiumCompany AnnouncementsHansoh’s Osteosarcoma Drug HS-20093 Hits Phase III Target, China Filing Planned
2M ago
3692
Why Is Penny Stock NextCure (NXTC) Up Today?
Premium
Market News
Why Is Penny Stock NextCure (NXTC) Up Today?
2M ago
NXTC
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
Premium
Company Announcements
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
3M ago
3692
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
PremiumCompany Announcements
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
3M ago
3692
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection
3M ago
3692
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
Hansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM
3M ago
3692
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication
4M ago
3692
Hansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
PremiumCompany AnnouncementsHansoh Pharmaceutical Reshapes Governance Team With New Joint Company Secretary
4M ago
3692
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
Premium
Company Announcements
Hansoh Pharma Sets 2026 AGM to Approve 2025 Results, Dividend and Share Mandates
4M ago
3692
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
Premium
Company Announcements
Hansoh Pharma’s Weight-Loss Drug Olatorepatide Wins NDA Acceptance in China
4M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >